671 related articles for article (PubMed ID: 26954295)
1. Resting-state connectivity predicts levodopa-induced dyskinesias in Parkinson's disease.
Herz DM; Haagensen BN; Nielsen SH; Madsen KH; Løkkegaard A; Siebner HR
Mov Disord; 2016 Apr; 31(4):521-9. PubMed ID: 26954295
[TBL] [Abstract][Full Text] [Related]
2. A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias.
Cerasa A; Koch G; Donzuso G; Mangone G; Morelli M; Brusa L; Stampanoni Bassi M; Ponzo V; Picazio S; Passamonti L; Salsone M; Augimeri A; Caltagirone C; Quattrone A
Brain; 2015 Feb; 138(Pt 2):414-27. PubMed ID: 25414038
[TBL] [Abstract][Full Text] [Related]
3. Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans.
Herz DM; Haagensen BN; Christensen MS; Madsen KH; Rowe JB; Løkkegaard A; Siebner HR
Brain; 2015 Jun; 138(Pt 6):1658-66. PubMed ID: 25882651
[TBL] [Abstract][Full Text] [Related]
4. Altered inhibitory interaction among inferior frontal and motor cortex in l-dopa-induced dyskinesias.
Ponzo V; Picazio S; Benussi A; Di Lorenzo F; Brusa L; Caltagirone C; Koch G
Mov Disord; 2016 May; 31(5):755-9. PubMed ID: 26861941
[TBL] [Abstract][Full Text] [Related]
5. Opposite effects of one session of 1 Hz rTMS on functional connectivity between pre-supplementary motor area and putamen depending on the dyskinesia state in Parkinson's disease.
Flamez A; Wu GR; Wiels W; Van Schuerbeek P; De Mey J; De Keyser J; Baeken C
Clin Neurophysiol; 2021 Apr; 132(4):851-856. PubMed ID: 33636601
[TBL] [Abstract][Full Text] [Related]
6. The motor inhibition system in Parkinson's disease with levodopa-induced dyskinesias.
Cerasa A; Donzuso G; Morelli M; Mangone G; Salsone M; Passamonti L; Augimeri A; Arabia G; Quattrone A
Mov Disord; 2015 Dec; 30(14):1912-20. PubMed ID: 26275050
[TBL] [Abstract][Full Text] [Related]
7. Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task.
Cerasa A; Pugliese P; Messina D; Morelli M; Gioia MC; Salsone M; Novellino F; Nicoletti G; Arabia G; Quattrone A
Mov Disord; 2012 Mar; 27(3):364-71. PubMed ID: 22076870
[TBL] [Abstract][Full Text] [Related]
8. Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias.
Cerasa A; Salsone M; Morelli M; Pugliese P; Arabia G; Gioia CM; Novellino F; Quattrone A
Parkinsonism Relat Disord; 2013 Oct; 19(10):883-8. PubMed ID: 23769805
[TBL] [Abstract][Full Text] [Related]
9. l-Dopa responsiveness is associated with distinctive connectivity patterns in advanced Parkinson's disease.
Akram H; Wu C; Hyam J; Foltynie T; Limousin P; De Vita E; Yousry T; Jahanshahi M; Hariz M; Behrens T; Ashburner J; Zrinzo L
Mov Disord; 2017 Jun; 32(6):874-883. PubMed ID: 28597560
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
[TBL] [Abstract][Full Text] [Related]
11. The acute brain response to levodopa heralds dyskinesias in Parkinson disease.
Herz DM; Haagensen BN; Christensen MS; Madsen KH; Rowe JB; Løkkegaard A; Siebner HR
Ann Neurol; 2014 Jun; 75(6):829-36. PubMed ID: 24889498
[TBL] [Abstract][Full Text] [Related]
12. Increased prefrontal volume in PD with levodopa-induced dyskinesias: a voxel-based morphometry study.
Cerasa A; Messina D; Pugliese P; Morelli M; Lanza P; Salsone M; Novellino F; Nicoletti G; Arabia G; Quattrone A
Mov Disord; 2011 Apr; 26(5):807-12. PubMed ID: 21384430
[TBL] [Abstract][Full Text] [Related]
13. Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias.
Piccini P; Weeks RA; Brooks DJ
Ann Neurol; 1997 Nov; 42(5):720-6. PubMed ID: 9392571
[TBL] [Abstract][Full Text] [Related]
14. Compensatory striatal-cerebellar connectivity in mild-moderate Parkinson's disease.
Simioni AC; Dagher A; Fellows LK
Neuroimage Clin; 2016; 10():54-62. PubMed ID: 26702396
[TBL] [Abstract][Full Text] [Related]
15. Cortical response to levodopa in Parkinson's disease patients with dyskinesias.
Turco F; Canessa A; Olivieri C; Pozzi NG; Palmisano C; Arnulfo G; Marotta G; Volkmann J; Pezzoli G; Isaias IU
Eur J Neurosci; 2018 Sep; 48(6):2362-2373. PubMed ID: 30117212
[TBL] [Abstract][Full Text] [Related]
16. Force overflow and levodopa-induced dyskinesias in Parkinson's disease.
Wenzelburger R; Zhang BR; Pohle S; Klebe S; Lorenz D; Herzog J; Wilms H; Deuschl G; Krack P
Brain; 2002 Apr; 125(Pt 4):871-9. PubMed ID: 11912119
[TBL] [Abstract][Full Text] [Related]
17. Altered Resting-State Functional Connectivity of the Striatum in Parkinson's Disease after Levodopa Administration.
Yang W; Liu B; Huang B; Huang R; Wang L; Zhang Y; Zhang X; Wu K
PLoS One; 2016; 11(9):e0161935. PubMed ID: 27611959
[TBL] [Abstract][Full Text] [Related]
18. Altered brain structural topological properties in Parkinson's disease with levodopa-induced dyskinesias.
Wang L; Wang M; Si Q; Yuan Y; Ma K; Gan C; Zhang K
Parkinsonism Relat Disord; 2019 Oct; 67():36-41. PubMed ID: 31621605
[TBL] [Abstract][Full Text] [Related]
19. Bilateral low frequency rTMS of the primary motor cortex may not be a suitable treatment for levodopa-induced dyskinesias in late stage Parkinson's disease.
Flamez A; Cordenier A; De Raedt S; Michiels V; Smetcoren S; Van Merhaegen-Wieleman A; Parys E; De Keyser J; Baeken C
Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26777410
[TBL] [Abstract][Full Text] [Related]
20. Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.
Cheshire P; Ayton S; Bertram KL; Ling H; Li A; McLean C; Halliday GM; O'Sullivan SS; Revesz T; Finkelstein DI; Storey E; Williams DR
Mov Disord; 2015 May; 30(6):796-804. PubMed ID: 25649148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
